Search Results - "Mališić, E."

PO-1823 XRCC3 Thr241Met gene polymorphism and acute radiotherapy induced toxicity for prostate cancer by Mališić, E., Petrović, N., Nikitović, M.

Get full text

456 RAD, TP53 and XRCC1 polymorphisms in triple-negative breast cancer by Krivokuca, A, Cavic, M, Malisic, E, Ivankovic, D. Kolarevic, Jankovic, R, Brankovic-Magic, M

Get full text

593: High incidence of EGFR gene mutations in Serbian female lung adenocarcinoma patients by Cavic, M, Krivokuca, A, Brotto, K, Malisic, E, Radulovic, S, Jankovic, R

Get full text

934: XRCC1 Arg399Gln polymorphism and susceptibility for hereditary BRCA1/2 negative breast cancer in Serbian women by Krivokuca, A, Malisic, E, Rakobradovic, J, Jankovic, R, Brankovic-Magic, M

Get full text

P080 Association of RNASEL rs12757998 polymorphism with normal tissue toxicity and fatigue induced by radiotherapy in prostate cancer patients by Mališić, E., Petrović, N., Petrović, M., Kopcalić, K., Milovanović, J., Ilić, B., Nikitović, M., Stanojković, T.

Get full text

KRAS and BRAF mutations in Serbian patients with colorectal cancer by Jakovljevic, K, Malisic, E, Cavic, M, Krivokuca, A, Dobricic, J, Jankovic, R

“…Mutations of KRAS and BRAF genes represent molecular biomarkers of response to targeted therapy in patients with metastatic colorectal cancer (mCRC). Since…”
Get more information

TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas by Malisic, E, Jankovic, R, Jakovljevic, K, Radulovic, S

“…Lack of symptoms in early stages of disease and resistance to chemotherapy make epithelial ovarian carcinomas one of the most lethal neoplasms among…”
Get more information

Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C by Radulovic, S, Brankovic-Magic, M, Malisic, E, Jankovic, R, Dobricic, J, Plesinac-Karapandzic, V, Maciag, P C, Rothman, J

“…Producing effective therapeutic vaccines has proved much more difficult and challenging than developing cancer preventive vaccines. Despite huge research in…”
Get more information

p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia by Malisic, E, Jankovic, R, Slavkovic, D, Milovic-Kovacevic, M, Radulovic, S

“…Ovarian cancer is the leading cause of death from gynecological malignancies. The early stages of this disease are asymptomatic and more than 75% of the cases…”
Get more information

103 KRAS mutational spectra in routine diagnostic analysis of metastatic colorectal cancer by Jakovljevic, K, Malisic, E, Dobricic, J, Spasic, M, Jankovic, R

Get full text

p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia by Malisic, E, Jankovic, R, Majkic, M, Dobricic, J, Radulovic, S

“…The incidence rate (age-standardized) of cervical carcinoma in Serbia is the highest in Europe. p53 is mainly inactivated at protein level in carcinomas…”
Get more information

p53 gene alterations and HPV16 infection in early stages of cervical carcinomas in Serbia by Malisic, E, Jankovic, R, Brankovic-Magic, M, Dobricic, J, Radulovic, S

Get full text

1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia by Cavic, M., Krivokuca, A., Damjanovic-Velickovic, A., Pavlovic, M., Mihajlovic, M., Rakobradovic, J., Boljevic, I., Malisic, E., Tanic, M., Jankovic, R.

Get full text

Relation of methylenetetrahydrofolate reductase C677T polymorphism to chronic myeloid leukemia in Serbia by Jankovic, R. N., Jakovljevic, K., Cavic, M., Malisic, E.

“…Abstract only…”
Get full text